An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of Schizophrenia
- Status
- TERMINATED
- Phase
- PHASE3
Related studies linked through entity extraction aliases.